Recent research has suggested that Casp6 mediates innate immunity and inflammasome activation [38] and it is related to axonal degeneration and cognitive impairment in Alzheimer's disease (AD) [39]. This evidence concerns the gene CASP6 and early-onset autosomal dominant Alzheimer disease.